Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...
New Omicron-specific vaccines offer similar protection to existing boosters
Eric Topol on X: "First data on booster vaccine effectiveness vs Omicron (581 cases): drop in protection vs symptomatic infection by 2 doses (AZ ->0, Pfizer-> <40%) restored to ~75% with 3rd
Vaccines | Free Full-Text | Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?
Eric Topol on X: "The decline of vaccine effectiveness vs Omicron. Simplified (no 95% CI) summary for Pfizer vaccine vs Delta, + booster, and vs Omicron, + booster (early @UKHSA data) vs
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron | NEJM
Efficacy of booster messenger ribonucleic acid COVID-19 vaccinations against SARS-CoV-2 Omicron variant severity
Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022 | MMWR
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar | NEJM
Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland | The University of Edinburgh
Does the Booster Protect Against Omicron?
Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants | Nature Medicine
Omicron: Three vaccine doses key for protection against variant - BBC News
Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design - The Lancet Infectious Diseases
COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England - The Lancet Infectious Diseases
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residents - eBioMedicine
Covid booster vaccines effective against severe illness from omicron, CDC says
COVID-19 vaccine surveillance report: week 15
Omicron – NIH Director's Blog
Effectiveness of primary series and booster vaccination against SARS-CoV-2 infection and hospitalisation among adolescents aged 12–17 years in Singapore: a national cohort study - The Lancet Infectious Diseases
Covid booster vaccines effective against severe illness from omicron, CDC says
Boosters wane but showed protection against hospitalization during omicron, CDC study says - The Washington Post
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant - ScienceDirect
Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil | Nature Communications
